Distribution of HCV genotypes in Belgium from 2008 to 2015.
Lobna BouacidaVanessa SuinVeronik HutseMichaël BoudewijnsReinoud CartuyvelsLaurent DebaisieuxEmmanuel De LaereMarie HallinNicolas HougardyKatrien LagrouEls OrisElizaveta PadalkoMarijke ReyndersGatien RousselJean-Marc SenterreMichel StalpaertDominique UrsiCarl VaelDolores VairaJos Van AckerWalter VerstrepenSteven Van GuchtBenoit KabambaSophie QuoilinGaëtan MuyldermansPublished in: PloS one (2018)
This national monitoring study allowed a clear and objective view of the circulating HCV genotypes in Belgium and will help health authorities in the establishment of cost effectiveness determinations before implementation of new treatment strategies. This baseline characterization of the circulating genotypes is indispensable for a continuous surveillance, especially for the investigation of the possible impact of migration from endemic regions and prior to the increasing use of highly potent direct-acting antiviral (DAA) agents.